Response to Stephane Renaud et al.
Journal
Radiotherapy and Oncology
Journal Volume
129
Journal Issue
1
Pages
188-189
Date Issued
2018
Author(s)
SDGs
Other Subjects
B Raf kinase; crizotinib; dabrafenib; epidermal growth factor receptor; epidermal growth factor receptor 2; brain metastasis; cancer radiotherapy; cancer survival; clinical outcome; Editorial; gene mutation; gene rearrangement; human; molecularly targeted therapy; oncogene; oncogene K ras; overall survival; priority journal; progression free survival; radiosensitivity; small cell lung cancer; stereotactic radiosurgery; treatment response
Publisher
Elsevier Ireland Ltd
Type
letter
